BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19729476)

  • 21. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
    Koike K
    Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.
    Naas T; Ghorbani M; Alvarez-Maya I; Lapner M; Kothary R; De Repentigny Y; Gomes S; Babiuk L; Giulivi A; Soare C; Azizi A; Diaz-Mitoma F
    J Gen Virol; 2005 Aug; 86(Pt 8):2185-2196. PubMed ID: 16033966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
    Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
    Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
    Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
    Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus core protein induces hepatic steatosis via Sirt1-dependent pathway.
    Zhang C; Wang J; Zhang H; Liu S; Lee HJ; Jin W; Cheng J
    Liver Int; 2018 May; 38(5):803-812. PubMed ID: 28898508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
    Hidaka I; Hino K; Korenaga M; Gondo T; Nishina S; Ando M; Okuda M; Sakaida I
    Liver Int; 2007 Aug; 27(6):845-53. PubMed ID: 17617128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.
    Perlemuter G; Lettéron P; Carnot F; Zavala F; Pessayre D; Nalpas B; Bréchot C
    J Hepatol; 2003 Dec; 39(6):1020-7. PubMed ID: 14642621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
    Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
    Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.
    Ferguson D; Zhang J; Davis MA; Helsley RN; Vedin LL; Lee RG; Crooke RM; Graham MJ; Allende DS; Parini P; Brown JM
    J Lipid Res; 2017 Feb; 58(2):420-432. PubMed ID: 27941027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models for hepatitis C and related liver disease.
    Koike K; Moriya K; Matsuura Y
    Hepatol Res; 2010 Jan; 40(1):69-82. PubMed ID: 20156300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.
    Chang ML; Yeh HC; Tsou YK; Wang CJ; Cheng HY; Sung CM; Ho YP; Chen TH; Yeh CT
    Obesity (Silver Spring); 2012 Jul; 20(7):1474-80. PubMed ID: 22421894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic alterations and hepatitis C: From bench to bedside.
    Chang ML
    World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis.
    Chang ML; Yeh CT; Chen JC; Huang CC; Lin SM; Sheen IS; Tai DI; Chu CM; Lin WP; Chang MY; Liang CK; Chiu CT; Lin DY
    BMC Genomics; 2008 Feb; 9():109. PubMed ID: 18307821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.
    Perlemuter G; Sabile A; Letteron P; Vona G; Topilco A; Chrétien Y; Koike K; Pessayre D; Chapman J; Barba G; Bréchot C
    FASEB J; 2002 Feb; 16(2):185-94. PubMed ID: 11818366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.
    Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Tsukamoto K; Kimura S; Moriya K; Koike K
    Gastroenterology; 2004 Mar; 126(3):840-8. PubMed ID: 14988838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
    Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
    Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein.
    Tsutsumi T; Matsuda M; Aizaki H; Moriya K; Miyoshi H; Fujie H; Shintani Y; Yotsuyanagi H; Miyamura T; Suzuki T; Koike K
    Hepatology; 2009 Aug; 50(2):378-86. PubMed ID: 19591124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species.
    Hara Y; Hino K; Okuda M; Furutani T; Hidaka I; Yamaguchi Y; Korenaga M; Li K; Weinman SA; Lemon SM; Okita K
    J Gastroenterol; 2006 Mar; 41(3):257-68. PubMed ID: 16699860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein.
    Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M
    Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.